INTERVIEW: Quintiles taking rough with the smooth in India
This article was originally published in Scrip
Executive Summary
A clutch of emerging opportunities in areas like biosimilars and centralized monitoring, and an uptrend in traditional strongholds like data management and pharmacovigilance, are propelling growth at Quintiles' Indian operations, even as uncertainties caused by evolving regulations are casting shadows over the country's clinical research sector.